Hyperthermia risk with meth use.

Hyperthermia risk with meth use.

• A. Hypothermia
• B. Hypotension
• C. Hyperthermia
• D. Hypoventilation

Answer: (C)

Hyperthermia is the primary risk with meth use. Meth is a strong stimulant that dramatically increases metabolic rate and physical activity, while also causing vasoconstriction. This combination boosts heat production and impairs the body’s ability to dissipate heat, especially during prolonged wakefulness or in hot environments. The result can be a dangerous rise in core body temperature, with potential for heat stroke, rhabdomyolysis, and organ injury. Hypothermia would involve cooling, which is not typical with stimulant use. Hypotension is less characteristic than hypertension and tachycardia in meth intoxication, and hypoventilation is more associated with depressants, not stimulants. So the best fit for the risk described with meth is hyperthermia.

Hyperthermia is the primary risk with meth use. Meth is a strong stimulant that dramatically increases metabolic rate and physical activity, while also causing vasoconstriction. This combination boosts heat production and impairs the body’s ability to dissipate heat, especially during prolonged wakefulness or in hot environments. The result can be a dangerous rise in core body temperature, with potential for heat stroke, rhabdomyolysis, and organ injury.

Hypothermia would involve cooling, which is not typical with stimulant use. Hypotension is less characteristic than hypertension and tachycardia in meth intoxication, and hypoventilation is more associated with depressants, not stimulants. So the best fit for the risk described with meth is hyperthermia.